FibroBiologics Inc (FBLG) Moves -4.69% Lower: These Numbers are Too Good to be True

As on Wednesday, FibroBiologics Inc (NASDAQ: FBLG) started slowly as it slid -4.69% to $0.72, before settling in for the price of $0.75 at the close. Taking a more long-term approach, FBLG posted a 52-week range of $0.70-$7.04.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Nevertheless, stock’s Earnings Per Share (EPS) this year is -28.85%. This publicly-traded company’s shares outstanding now amounts to $37.74 million, simultaneously with a float of $27.42 million. The organization now has a market capitalization sitting at $27.47 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9331, while the 200-day Moving Average is $1.8381.

FibroBiologics Inc (FBLG) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. FibroBiologics Inc’s current insider ownership accounts for 28.35%, in contrast to 16.93% institutional ownership. According to the most recent insider trade that took place on May 27 ’25, this organization’s Chief Scientific Officer bought 20,000 shares at the rate of 0.84, making the entire transaction reach 16,800 in total value, affecting insider ownership by 31,250. Preceding that transaction, on Aug 12 ’24, Company’s Chief Executive Officer bought 8,500 for 1.91, making the whole transaction’s value amount to 16,269. This particular insider is now the holder of 6,056,647 in total.

FibroBiologics Inc (FBLG) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.

FibroBiologics Inc’s EPS decrease for this current 12-month fiscal period is -28.85% and is forecasted to reach -0.46 in the upcoming year.

FibroBiologics Inc (NASDAQ: FBLG) Trading Performance Indicators

Let’s observe the current performance indicators for FibroBiologics Inc (FBLG). It’s Quick Ratio in the last reported quarter now stands at 1.14. The Stock has managed to achieve an average true range (ATR) of 0.09.

In the same vein, FBLG’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.21, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.46 at the market close of one year from today.

Technical Analysis of FibroBiologics Inc (FBLG)

Through scrutinizing the latest numbers posted by the [FibroBiologics Inc, FBLG], it can be observed that its last 5-days Average volume of 0.26 million was lower the volume of 0.27 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 8.00% While, its Average True Range was 0.0833.

Raw Stochastic average of FibroBiologics Inc (FBLG) in the period of the previous 100 days is set at 1.29%, which indicates a major fall in contrast to 5.78% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 84.22% that was lower than 107.54% volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.